Ovarian cancer cell line panel (OCCP): Clinical importance of in vitro morphological subtypes
- Beaufort, C.M. (Corine M.)
- Helmijr, J. (Jean)
- Piskorz, A.M. (Anna M.)
- Hoogstraat, M. (Marlous)
- Ruigrok-Ritstier, K. (Kirsten)
- Besselink, N. (Nicolle)
- Murtaza, M. (Muhammed)
- IJcken, W.F.J. (Wilfred) van
- Heine, A.A.J. (Anouk)
- Smid, M. (Marcel)
- Koudijs, M.J. (Marco J.)
- Brenton, J.D. (James D.)
- Berns, P.M.J.J. (Els)
- Helleman, J. (Jozien)
Publication date
September 2014
DOI Publisher
Public Library of Science (PLoS) ISSN
1932-6203 Citation count (estimate)
60Abstract
Epithelial ovarian cancer is a highly heterogeneous disease and remains the most lethal gynaecological malignancy in the Western world. Therapeutic approaches need to account for inter-patient and intra-tumoural heterogeneity and detailed characterization of in vitro models representing the different histological a
Add to ORKG